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The in vitro DNA-binding activity of the C2 protein of tomato yellow leaf curl geminivirus (TYLCV) was studied following
its expression in Escherichia coli as a fusion protein with an His tag N-terminal extension (His-C2). Southwestern blotting
experiments demonstrated that the C2 protein is able to bind both single-stranded and double-stranded DNA probes. In
electrophoretic mobility shift assays performed using purified protein and single-stranded DNA probes several shifted
complexes were formed. The presence of NaCl (up to 800 mM) did not substantially affect binding profiles, demonstrating
a stable interaction. His-C2 appeared to bind single-stranded DNA in a sequence-nonspecific manner, with a preference
for single-stranded compared to double-stranded DNA. Deletion mutants demonstrated that the central core of C2 (amino
acids 33 to 104), which contains a Cys-His rich region, is sufficient for conferring binding activity. The potential significance
of this DNA-binding activity with respect to possible biological functions of TYLCV C2 protein is discussed. q 1996 Academic
Press, Inc.
Tomato yellow leaf curl virus (TYLCV) is an important genome and displays a typical iterative structure (11).
Two ORFs [capsid protein (CP) and V2] are located onpathogen of tomato crops, occurring in several regions
from the Mediterranean basin to southeastern Asia, In- the virion sense strand, while four ORFs (C1 to C4) are
on the complementary sense strand. ORF C1 codes fordia, and Africa (1). TYLCV, which includes several iso-
lates grouped in at least three species (2), belongs to the viral replication initiator protein (Rep protein; 12). Mu-
tagenesis of ORFs CP, V2 (13), C4 (14) revealed that theythe Geminiviridae family, subgroup III. This family is char-
acterized by twinned quasi isometric particles with a cir- are dispensable for replication but are all required for
infection of tomato plants.cular single-stranded (ss) DNA genome that replicates
in the nucleus of infected cells through a double- TYLCV C2 gene and protein share a high level of simi-
larity with the corresponding ORF and protein of otherstranded (ds) intermediate (3, 4). The virus is transmitted
by the whitefly Bemisia tabaci to dicotyledonous plants. geminiviruses (GVs) of subgroup III. In bipartite GVs, the
In contrast to the other members of the subgroup, such viral protein homologous to C2 is termed AL2 or AC2.
as tomato golden mosaic virus (TGMV) and African cas- TGMV AL2 is required for CP and viral ssDNA accumula-
sava mosaic virus (ACMV), whose genomes are com- tion (15–17). It was suggested in (17) that accumulation
posed of two similarly sized DNA molecules, termed A of ssDNA was dependent on the presence of viral CP,
and B, most TYLCVs have a monopartite genome. A which in turn depended on a functional AL2 gene prod-
TYLCV from Thailand possessing a DNA B molecule has uct. Later, it was shown that AL2 activates the expression
also been described (5); however, DNA B is not required of the CP and BR1 genes in TGMV (18) and the expres-
for infection of tomato plants. The nucleotide sequence sion of CP, BR1, and BL1 genes in ACMV (19). Recently,
of several TYLCV isolates has been determined (6–10) Sung and Coutts (20) proposed that AL2 of potato yellow
showing an identical genome organization (Fig. 1). mosaic geminivirus might act similarly.
TYLCV DNA codes for six ORFs, organized in two tran- A mutant TYLCV DNA unable to produce C2 can repli-
scription units. These are separated by an intergenic cate in protoplasts but cannot systemically infect tomato
region (IR) of about 300 nt that contains key regulatory plants (I. Jupin and E. Noris, in preparation). Although no
elements for the replication and transcription of the viral evidence for transactivation of viral genes is available in
the case of TYLCV, the similarity of sequences and of
domain organization existing between the TYLCV C2 pro-
1 To whom correspondence and reprint requests should be ad-
tein and its counterpart AL2 in bipartite GVs led us todressed. Fax: 39-11-343809. E-mail: noris@ifa.to.cnr.it.
speculate that this protein may have a similar function2 Present address: Institut J.Monod, 2 Place Jussieu, 75251 Paris,
France. and may be required for the expression of other viral
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FIG. 1. Genomic map of TYLCV. The arrangement of the primers used for cloning the C2 ORF and its deletion mutants and the restriction sites
used for the preparation of the probes are displayed. Nucleotide numbering is according to (7).
proteins. The possibility that C2 might interact with viral from bacteria were fractionated by SDS–PAGE, blotted
onto nitrocellulose membranes, and renatured. Mem-promoters raises a question about its ability to bind to
DNA. In this paper, we have studied the DNA-binding branes were then incubated for 4 hr at 47 with 2500 cpm/
cm2 of 32P-labeled random-primed DNA probe, either un-activity of TYLCV C2 protein and found that the protein is
able to bind ss- and dsDNA, with no apparent sequence treated (ds form) or treated at 1007 for 5 min (ss form).
Salmon sperm DNA (10 mg/ml) was added as a nonspe-specificity and that the DNA-binding domain is located
in the central core of the protein. cific competitor. Membranes were washed in the pres-
ence of 50 mM NaCl and exposed to X-ray films. TheTo prepare C2 protein for the assessment of its DNA-
binding activity, TYLCV ORF C2 from the Sardinian isolate probe used consisted of a 305-nt (BspMII– BamHI) re-
striction fragment corresponding to the IR of TYLCV (24).(TYLCV-Sar) [nt 1626–1219 according to (7)] was ampli-
fied by PCR using primers 1 (5*-GACCATGGCCCGGGC- This region contains the conserved hairpin loop se-
quence, promoters, and other regulatory elements of viralATATGCAATCTTCGTCA-3* ) and 2 (5*-ACTCGAGCC-
CGGGATCCTTAAAGACTCTTAAA-3* ), which provided gene expression (25), hence represents a proper target
for putative viral transcription factors. In induced bacte-NdeI and XhoI restriction sites at the 5* and 3* termini
of the gene, respectively. The NdeI/XhoI-cut fragment rial extracts a protein, with electrophoretic mobility identi-
cal to His-C2 (Fig. 2A, lane 7), was able to bind thewas cloned in the identically restricted pET-15b expres-
sion vector (Novagen Inc.) to give pTom106, capable of labeled DNA in either ss or ds form (lanes 2 and 4,
respectively). This protein reacted with antibodies pre-producing a fusion protein (His-C2) with an N-terminal
extension of 20 amino acids, including a tag of six histi- pared against His-C2 (not shown). Several other bacterial
DNA-binding proteins were also present (lanes 1 to 4).dines and a thrombin cleavage site. Following transfor-
mation of Escherichia coli BL21 (pLysS) (21) with The DNA-C2 protein complexes were still clearly visible
after washes in the presence of 500 mM NaCl (notpTom106, the protein was expressed by induction of the
T7 DNA polymerase promoter with 0.1 mM IPTG for 5 hr shown), indicating the occurrence of a stable interaction.
To confirm that the DNA-binding activity was indeed dueat 377 in M9 medium. Although various induction condi-
tions were tested, His-C2 always formed insoluble inclu- to the C2 protein, and to rule out a possible contribution
of the N-terminal histidine tag, the purified His-C2 proteinsion bodies. The protein was then purified essentially as
described by Citovsky et al. (22). Briefly, the procedure (1 mg) was digested with thrombin (0.0016 U) in 10 mM
Tris–HCl, pH 9, 150 mM NaCl, 2.5 mM CaCl2 , for 30 mininvolved purification of insoluble inclusion bodies from
an induced culture by three cycles of freezing and thaw- at 307. C2 protein, thus deprived of the histidine tag, was
still capable of binding to DNA with an affinity similar toing, followed by sonication in lysis buffer (25 mM Tris –
HCl, pH 8, 10 mM glucose, 1 mM EDTA, 0.1 mg/ml lyso- the unprocessed protein (Fig. 2A, lanes 5 and 6).
To analyze in more detail the characteristics of thezyme), their solubilization in buffer L [10 mM Tris–HCl,
pH 8, 200 mM NaCl, 10% glycerol, 1 mM DTT, 1 mM DNA-binding activity of His-C2, electrophoretic mobility
shift assays (EMSA) were performed using the purifiedphenylmethylsulfonyl fluoride (PMSF), 1 mM EDTA, 4 M
urea] at 707 for 5 min, and the renaturation of the solubilized protein. Typical binding reactions contained 100 ng of
protein in 20 ml binding buffer (20 mM Hepes, pH 7.5, 40His-C2 protein by dialysis against 5 mM Tris–HCl, pH 8,
0.5 mM EDTA, 2 mM DTT, 1 mM PMSF in the presence of mM KCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 10 mM [4-
amidinophenyl]-methanesulfonyl fluoride) and included 1decreasing urea concentrations (2 to 0 M). This method
allowed us to obtain protein preparations purified to near ng of labeled DNA (104 cpm) and 2 mg poly(dI-dC) as
heterologous competitor. The probe was prepared fromhomogeneity, as shown in Fig. 2A, lane 7.
The DNA-binding activity was first assessed by the the above described IR DNA fragment, end-labeled with
T4 polynucleotide kinase and [g-32P]ATP, and used eithersouthwestern blotting (SW) procedure, according to Pa-
pavassiliou and Bohmann (23). Crude protein extracts heat denatured (ss form) or untreated (ds form). After
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FIG. 2. Binding of His-C2 to TYLCV IR DNA probe in SW (A) and in EMSA (B). (A) Total bacterial extracts from noninduced (lanes 1 and 3) and
induced (lanes 2 and 4) E. coli BL21(pLysS) cells carrying pTom106 were separated in 18% SDS–PAGE gels and tested with either ss (lanes 1 and
2) or ds (lanes 3 and 4) probe. Bacterial DNA-binding proteins present in total extracts (lanes 1 to 4) are eliminated following His-C2 purification
(lane 5). Removal of the His tag with thrombin does not affect the binding activity of C2 (lane 6). Purified His-C2 stained with Coomassie brilliant
blue is shown in lane 7. (B) The ss probe was incubated in the presence of increasing amounts of purified (as shown in A, lane 7) His-C2 protein.
0, 20, 60, 100, and 160 ng of protein were used in lanes 1, 2, 3, 4, and 5, respectively. The effect of removal of poly(dI-dC) is shown in lane 6.
Binding experiments performed with 100 ng of protein in the presence of 100, 400, and 800 mM NaCl are run in lanes 7, 8, and 9, respectively.
Incubation of the ds probe without or with His-C2 protein (100 ng) is shown in lanes 10 and 11, respectively.
20 min incubation at room temperature, samples were study in more detail the dsDNA binding by EMSA. We
believe that these variations arose from different degreesloaded on a 4% polyacrylamide gel, run in 0.51 TBE,
dried on Whatman paper and exposed to X-ray films. of renaturation during the final protein purification steps.
The specificity of the binding was analyzed by SWWhen His-C2 was incubated with ss IR DNA, discrete
complexes of retarded mobility were obtained (Fig. 2B, and EMSA, using DNA probes prepared either from the
TYLCV genome (a 314-bp BamHI–SstII fragment cov-lanes 2 to 9). Treatment of the samples with proteinase
K abolished the formation of retarded complexes (not ering part of ORF V2 and CP and a 333-bp SstI–PflMI
fragment covering part of ORF C1) or nonviral DNA (ashown) demonstrating protein-mediated mobility shift. In-
creasing the amount of protein in the binding reaction 322-bp PvuII fragment from pUC118). In SW assays, His-
C2 was able to bind all fragments, in a ss as well as ds(from 20 to 160 ng) resulted in the appearance of addi-
tional retarded bands (lanes 2 to 5), with a progressive form, with an efficiency similar to that observed with the
TYLCV IR region (not shown). Similarly, when the samereduction of the unbound probe. These complexes are
likely to correspond to the binding of additional protein fragments were used as ssDNA probes in EMSA, dis-
crete complexes of retarded electrophoretic mobilitymolecules to the DNA probe.
Since DNA-binding activity may depend on salt con- were obtained with all probes, including a number of
other restriction fragments from the TYLCV genome orcentration and on incubation time, studies on the kinetics
were performed and different buffer compositions were from pUC118 or pBluescript KS/ plasmids (not shown).
Thus the binding of His-C2 to DNA appears not to betested. Incubation times as short as 0.5 min were suffi-
cient for complex formation. Presence of divalent cations sequence-specific.
To further investigate the sequence specificity, compe-such as Mg2/ (5 mM) or Zn2/ (2 mM) did not alter the
pattern of DNA–protein complexes observed (not tition assays were performed using TYLCV IR ssDNA as
probe. Homologous or heterologous unlabeled frag-shown), indicating that these two cations were not neces-
sary for a more efficient binding affinity. When binding ments were used at different molar ratios. Both competi-
tors inhibited complex formation (Fig. 3, lanes 3 to 8), butreactions were performed in the presence of 100, 400,
and 800 mM NaCl, formation of protein–DNA complexes the homologous fragment appeared to be more efficient
in competing with the probe. However, we think that thisalso took place (lanes 7–9), the highest NaCl concentra-
tion only partially altering the pattern (lane 9), thus indi- difference in competition efficiency does not reflect a
difference in the binding strength of C2, but is rather duecating the high stability of the interaction. Removal of
poly(dI-dC) from the binding reaction further increased to a partial renaturation of the probe with the homologous
competitor (see lower band in Fig. 3, lanes 4 and 5). Inthe multiplicity of the retarded bands (compare lanes 6
and 4), indicating that in the standard reaction part of fact, similar results were also obtained when the PvuII
fragment from pUC118 was used in the presence of ho-the protein bound to the heterologous competitor. Con-
versely, when His-C2 was incubated with the dsDNA mologous competitor. These experiments further confirm
that the binding of His-C2 to DNA is not sequence-depen-probe, the mobility of the probe was altered, but a diffuse
smear rather than a discrete complex appeared (lane dent. When a 100 molar excess of IR dsDNA competitor
was added to labeled IR ssDNA no modification of the11). However, differences in the binding activity among
several batches of purified proteins did not allow us to pattern typically observed with ssDNA probes occurred
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rately primers 1 and 4 (5*-GCGGATCCTCGAGTTATT-
GTGGTTGAATCTGAT-3* ), primers 3 (5*-CCATGGATC-
ATATGGTAGATCTGGACTGTGG-3* ) and 2, and primers
3 and 4. These fragments were digested by NdeI and
XhoI, both sites provided by the adaptor arms of primers,
and cloned in pET15b to give pTom206, pTom204, and
pTom205, respectively. The corresponding proteins were
expressed in E. coli as described above for pTom106.
Protein B-CC encoded by pTom206 lacks the 31 C-termi-
nal amino acids of C2. Protein CC-A encoded byFIG. 3. Competition assays for DNA binding to C2. Labeled TYLCV
pTom204 is deprived of the 33 N-terminal amino acids,IR DNA (lane 1) was incubated in presence of no competitor (lane 2),
while protein CC corresponds to the 71 central aminohomologous competitor (lanes 3, 4, and 5, containing 25, 50, and 100 ng,
respectively) or heterologous competitor (PvuII fragment from pUC118; acids (aa 33 to 104). All three proteins were expressed
lanes 6, 7, and 8, containing 25, 50, and 100 ng, respectively). All in bacteria following IPTG induction and were recognized
reactions, except that shown in lane 1, contained 100 ng of purified by the above mentioned antibodies produced against
C2 protein.
His-C2 (Fig. 4B, lanes 4, 9, and 13). Their ability to bind
DNA was assessed by the SW procedure on crude bacte-
(not shown), indicating a preference of His-C2 for ssDNA rial extracts, using ss- and dsDNA probes corresponding
versus dsDNA. to the TYLCV IR. As shown in Fig. 4B, all three deletion
Furthermore, in the course of the experiments we ob- mutants retained the capacity to bind DNA (lanes 2, 7,
served that when the homologous competitor (100 molar and 11). In the case of the CC mutant that co-migrated
excess) was added after complex formation rather than with an endogenous bacterial DNA-binding protein, in-
before, it was not effective in destabilizing the complexes clusion bodies were prepared and used to confirm the
(not shown). authenticity of the complex (lanes 6 and 7). It should be
In order to test whether His-C2 was also able to bind noted, however, that B-CC and CC showed a lower bind-
RNA, we synthesized in vitro transcripts corresponding ing activity than the wild-type His-C2 protein. Whether
to several regions of the TYLCV genome and tested them this reflects a contribution of the C-terminal domain to the
in gel retardation assays, using the standard EMSA pro- binding, a different protein assembly and/or renaturation
tocol described above. In the conditions tested, we failed efficiency, or a different level of expression among mu-
to demonstrate any complex formation (not shown). tant proteins remains to be clarified.
The AL2/C2 proteins of several whitefly-transmitted Among the structural domains tentatively identified for
GVs share a similar domain organization (18) with an N- the GV AL2/C2 proteins (18), two domains were consid-
terminal basic domain (B) and a stretch of acidic residues ered potential candidates for a DNA-binding activity, i.e.,
in the C-terminal domain (A). The two charged domains the basic N-terminal region and the central Cys-His rich
are separated by a central core (CC) containing con- core. This region has been proposed to form a zinc-finger
served cysteine and histidine residues (Fig. 4A). To iden- motif (18), but experimental evidence is as yet missing.
tify the DNA-binding domain of the protein, three deletion Cys-His boxes involved in specific nucleic acid binding
mutants were constructed. For this purpose, DNA frag- have been identified in several organisms (26). From our
ments spanning nt 1625 –1314, 1529–1218, and 1529 – results it is evident that the central core of C2 protein is
sufficient to confer DNA-binding activity.1314 were obtained by PCR amplification using sepa-
FIG. 4. Identification of the DNA-binding domain of C2. (A) Schematic representation of TYLCV C2 protein and its deletion mutants. (B) SW assay
of total protein extracts from E. coli cells, carrying pTom204 (lanes 1 and 2), pTom205 (lanes 5 and 6), and pTom206 (lanes 10 and 11), either
noninduced (lanes 1, 5, and 10) or induced (lanes 2, 6, and 11) probed with the ss IR DNA of TYLCV. In the case of pTom205 inclusion bodies
were assayed in order to eliminate contaminating comigrating bacterial DNA-binding proteins (lane 7). The higher MW DNA-binding protein is
presumably an E. coli protein that copurifies with the inclusion bodies. Lanes 3 and 4, 8 and 9, 12 and 13 are Western blots (obtained with anti-
C2 antibodies) from either noninduced or induced bacteria, used to demonstrate the expression of the mutant proteins (marked by the arrows).
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The experiments described in this paper show that that the two proteins lacking both terminal domains still
bind DNA. Functions of Gp32 throughout replication em-TYLCV C2 can form stable complexes with ssDNA (and
less preferably with dsDNA) and that the binding is se- brace binding to template strand at the replication fork,
effecting local unwinding, extending the template into aquence nonspecific. AL2 of subgroup III GVs was shown
to be involved in the activation of other viral genes and conformation optimal for base pairing and replication,
and protecting ssDNA against nucleases. Unlike Gp32,was considered as a transcriptional activator (17). How-
ever, transcription factors usually show a high sequence the role of Gp5 is to interrupt the synthesis of the duplex
replicative forms and to prepare the DNA for packagingspecificity. In order to explain our results and help to
elucidate the role of TYLCV C2, two different hypotheses into the virus particle. M13 Gp5 mutants do not produce
viral strands, but conversely accumulate the duplex repli-are proposed:
cative form, a condition similar to that described for some
(i) C2 has sequence specificity, but we have been un-
GVs (15, 17). However, in the case of a C2 mutant of
able to see it due to the requirement of essential post-
TYLCV (I. Jupin and E. Noris, in preparation), no evident
translational modifications. For example, protein phos-
difference in ss- vs dsDNA accumulation could be ob-
phorylation in transcription factors has been shown to
served.
be important for specific DNA-binding (27, 28). Several
Complementation experiments between TYLCV C2
putative phosphorylation sites are present in the se-
and other GVs and a search for its possible trans-activat-
quence of TYLCV C2 protein, some of which are con-
ing activity will help to identify the role of this protein in
served among subgroup III GVs. Phosphorylation and/or
the viral infection cycle.
other factors might be responsible for a particular protein
conformation that enables specific DNA binding. Con-
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